Benchmarking Drug Safety and Pharmacovigilance

Friday, April 23, 2010 General News J E 4
Benchmarking Drug Safety and Pharmacovigilance Reinforce Your Drug Safety Team Benchmarking Drug Safety and Pharmacovigilance is a data-driven guide to optimizing your companys drug safety efforts. Designed for drug safety teams that work with clinical and post-marketed products this study details budgets and outsourcing structure and staffing activities timing and communications. Beyond quantitative analysis top executives reveal best practices creative solutions to ongoing challenges and their unique perspectives on current trends. ( ) Leverage and maximize your resources Drug safety is an essential function but it is not immune to the budget cuts occurring across the industry. If companies do not fund drug safety adequately however they can open themselves up to risk. Whats more drug safety teams must have the flexibility to evolve stay on technologys cutting edge and keep up with ever-changing safety demands. Budgets and Outsourcing: Win more resources and defend the budget you already have even as other groups face cuts. See how other teams balance workloads via outsourcing to gauge your own mix of in-house/outsourced tasks. Structure and Staffing: Use our benchmarks to reinforce your thinking around group structure and tools. Identify the types of positions necessary to run the simplest of organizations and the best structures at companies of all sizes. Activities: Learn how several groups throughout the organization must play an active role in the companys pharmacovigilance activities. Metrics include activities timing and communication strategies to encourage better knowledge transfer. Trumpet the value of your team Because drug safety and pharmacovigilance are necessary functions your team may not spend much time thinking about ROI. In fact drug safety veterans say it is crucial to communicate successes and prove strategic value. Discover how other groups address this challenge and work to build a drug safety culture in their organizations. Improve communication with the FDA Drug teams must stay up to date on all agency changes but that sometimes means working under one governing guidance while a contradictory draft guidance awaits approval. Implement best practices to resolve such confusion as you improve your companys communication processes with regulatory agencies including the FDA. To know more and to buy a copy of your report feel free to visit : Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Blog: Follow us on twitter:


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Cl...
IDEXX Laboratories Announces First Quarter Results